The State Drug Regulatory Authorities overseas, responsible for the assessment of manufacturing standards according to GMP principle, have postponed the assessment of manufacturers located inside and outside the authority’s country due to the ongoing COVID-19 pandemic. Therefore, these drug regulatory authorities have determined that GMP certificates are still valid until the next round of assessment.
Therefore, on 7th October 2022, The Food and Drug Administration Thailand announced temporary measures on GMP clearance certification of Pharmaceutical manufacturers regarding the pandemic situation of COVID-19 on 30 September 2022. Such action includes extending the validity of the GMP clearance approval letter and updating the requirement and process of submission and renewal.
More details can be found here: https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Law04-Notification-ThFDA/FDA-20220930.pdf